SEATTLE (AP) _ Omeros Corporation (OMER) on Monday reported a loss of $37.3 million in its fourth quarter.
The Seattle-based company said it had a loss of 60 cents per share. Losses, adjusted for non-recurring costs, were 54 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 64 cents per share.
The drug developer posted revenue of $10.6 million in the period.
For the year, the company reported that its loss widened to $138.1 million, or $2.41 per share. Revenue was reported as $73.8 million.
Omeros shares have risen 36% since the beginning of the year. In the final minutes of trading on Monday, shares hit $19.41, a rise of 64% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMER at https://www.zacks.com/ap/OMER
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News